175 related articles for article (PubMed ID: 17361921)
1. [Management of gynecomastia induced by bicalutamide].
Haddad E
Ann Urol (Paris); 2006 Dec; 40 Suppl 2():S49-52. PubMed ID: 17361921
[TBL] [Abstract][Full Text] [Related]
2. Gynecomastia and breast pain induced by adjuvant therapy with bicalutamide after radical prostatectomy in patients with prostate cancer: the role of tamoxifen and radiotherapy.
Di Lorenzo G; Perdonà S; De Placido S; D'Armiento M; Gallo A; Damiano R; Pingitore D; Gallo L; De Sio M; Autorino R
J Urol; 2005 Dec; 174(6):2197-203. PubMed ID: 16280763
[TBL] [Abstract][Full Text] [Related]
3. [Gynecomastia as a complication of hormonotherapy for prostate cancer: effect of prophylactic breast irradiation].
Abdah-Bortnyak R; Bernstein Z; Ramon N; Zalman D; Shnaider J; Kuten A
Harefuah; 2007 Feb; 146(2):126-8, 164-5. PubMed ID: 17352282
[TBL] [Abstract][Full Text] [Related]
4. Editorial comment on: Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-response study.
Van Poppel H
Eur Urol; 2007 Jul; 52(1):115. PubMed ID: 17270341
[No Abstract] [Full Text] [Related]
5. Treatment of bicalutamide-induced breast events.
Sieber PR
Expert Rev Anticancer Ther; 2007 Dec; 7(12):1773-9. PubMed ID: 18062751
[TBL] [Abstract][Full Text] [Related]
6. An open, randomised, multicentre, phase 3 trial comparing the efficacy of two tamoxifen schedules in preventing gynaecomastia induced by bicalutamide monotherapy in prostate cancer patients.
Bedognetti D; Rubagotti A; Conti G; Francesca F; De Cobelli O; Canclini L; Gallucci M; Aragona F; Di Tonno P; Cortellini P; Martorana G; Lapini A; Boccardo F
Eur Urol; 2010 Feb; 57(2):238-45. PubMed ID: 19481335
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-response study.
Fradet Y; Egerdie B; Andersen M; Tammela TL; Nachabe M; Armstrong J; Morris T; Navani S
Eur Urol; 2007 Jul; 52(1):106-14. PubMed ID: 17270340
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial comparing tamoxifen therapy vs. tamoxifen prophylaxis in bicalutamide-induced gynecomastia.
Serretta V; Altieri V; Morgia G; Nicolosi F; De Grande G; Mazza R; Melloni D; Allegro R; Ferraù F; Gebbia V
Clin Genitourin Cancer; 2012 Sep; 10(3):174-9. PubMed ID: 22502790
[TBL] [Abstract][Full Text] [Related]
9. Treatment strategies to prevent and reduce gynecomastia and/or breast pain caused by antiandrogen therapy for prostate cancer : Statement from the DEGRO working group prostate cancer.
Ghadjar P; Aebersold DM; Albrecht C; Böhmer D; Flentje M; Ganswindt U; Höcht S; Hölscher T; Müller AC; Niehoff P; Pinkawa M; Sedlmayer F; Zips D; Wiegel T;
Strahlenther Onkol; 2020 Jul; 196(7):589-597. PubMed ID: 32166452
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynaecomastia and breast pain caused by bicalutamide in prostate cancer: a randomised controlled trial.
Perdonà S; Autorino R; De Placido S; D'Armiento M; Gallo A; Damiano R; Pingitore D; Gallo L; De Sio M; Bianco AR; Di Lorenzo G
Lancet Oncol; 2005 May; 6(5):295-300. PubMed ID: 15863377
[TBL] [Abstract][Full Text] [Related]
11. Images in clinical medicine. Gynecomastia induced by prostate-cancer treatment.
Michalopoulos NV; Keshtgar MR
N Engl J Med; 2012 Oct; 367(15):1449. PubMed ID: 23050528
[No Abstract] [Full Text] [Related]
12. The role of tamoxifen in reducing bicalutamide-induced gynaecomastia and breast pain.
Nuttall MC; Harris JP; Dawkins GP
BJU Int; 2007 Feb; 99(2):243-4. PubMed ID: 17313420
[No Abstract] [Full Text] [Related]
13. Is prophylactic breast radiotherapy necessary in all patients with prostate cancer and gynecomastia and/or breast pain?
Ozen H; Akyol F; Toktas G; Eskicorapci S; Unluer E; Kuyumcuoglu U; Abay E; Cureklibatur I; Sengoz M; Yalcin V; Akpinar H; Zorlu F; Sengor F; Karaman I
J Urol; 2010 Aug; 184(2):519-24. PubMed ID: 20620411
[TBL] [Abstract][Full Text] [Related]
14. Antiandrogen monotherapy in patients with localized or locally advanced prostate cancer: final results from the bicalutamide Early Prostate Cancer programme at a median follow-up of 9.7 years.
Iversen P; McLeod DG; See WA; Morris T; Armstrong J; Wirth MP;
BJU Int; 2010 Apr; 105(8):1074-81. PubMed ID: 22129214
[TBL] [Abstract][Full Text] [Related]
15. Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer.
Shipley WU; Seiferheld W; Lukka HR; Major PP; Heney NM; Grignon DJ; Sartor O; Patel MP; Bahary JP; Zietman AL; Pisansky TM; Zeitzer KL; Lawton CA; Feng FY; Lovett RD; Balogh AG; Souhami L; Rosenthal SA; Kerlin KJ; Dignam JJ; Pugh SL; Sandler HM;
N Engl J Med; 2017 Feb; 376(5):417-428. PubMed ID: 28146658
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer.
Boccardo F; Rubagotti A; Battaglia M; Di Tonno P; Selvaggi FP; Conti G; Comeri G; Bertaccini A; Martorana G; Galassi P; Zattoni F; Macchiarella A; Siragusa A; Muscas G; Durand F; Potenzoni D; Manganelli A; Ferraris V; Montefiore F
J Clin Oncol; 2005 Feb; 23(4):808-15. PubMed ID: 15681525
[TBL] [Abstract][Full Text] [Related]
17. Bicalutamide-induced gynaecomastia: do we have the answer?
Di Lorenzo G; Autorino R
Eur Urol; 2007 Jul; 52(1):5-8. PubMed ID: 17258386
[No Abstract] [Full Text] [Related]
18. Prevention and management of bicalutamide-induced gynecomastia and breast pain: randomized endocrinologic and clinical studies with tamoxifen and anastrozole.
Saltzstein D; Sieber P; Morris T; Gallo J
Prostate Cancer Prostatic Dis; 2005; 8(1):75-83. PubMed ID: 15685254
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapeutic prophylaxis of gynecomastia.
Thönnessen D; Wenz F
J Clin Oncol; 2005 Aug; 23(24):5845; author reply 5846-7. PubMed ID: 16110041
[No Abstract] [Full Text] [Related]
20. Prophylactic breast irradiation with a single dose of electron beam radiotherapy (10 Gy) significantly reduces the incidence of bicalutamide-induced gynecomastia.
Tyrrell CJ; Payne H; Tammela TL; Bakke A; Lodding P; Goedhals L; Van Erps P; Boon T; Van De Beek C; Andersson SO; Morris T; Carroll K
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):476-83. PubMed ID: 15380582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
